(Q40811138)

English

Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12.

scientific article published on February 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12. (English)

1 reference

Europe PubMed Central

23 September 2017

1 reference

based on heuristic

inferred from title

author name string

Chen Y

1

1 reference

Europe PubMed Central

23 September 2017

Emtage P

2

1 reference

Europe PubMed Central

23 September 2017

Zhu Q

3

1 reference

Europe PubMed Central

23 September 2017

Foley R

4

1 reference

Europe PubMed Central

23 September 2017

Muller W

5

1 reference

Europe PubMed Central

23 September 2017

Hitt M

6

1 reference

Europe PubMed Central

23 September 2017

Gauldie J

7

1 reference

Europe PubMed Central

23 September 2017

Wan Y

8

1 reference

Europe PubMed Central

23 September 2017

publication date

1 February 2001

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

8

1 reference

Europe PubMed Central

23 September 2017

316-323

1 reference

Europe PubMed Central

23 September 2017

4

1 reference

Europe PubMed Central

23 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301396

0 references

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

Oncogenic proteins as tumor antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

Protection against mammary tumor growth by vaccination with full-length, modified human ErbB-2 DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

CD4 T cells and their role in antitumor immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

How do cytotoxic lymphocytes kill their targets?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

Construction of a Double Recombinant Adenovirus Vector Expressing a Heterodimeric Cytokine: In Vitro and In Vivo Production of Biologically Active Interleukin-12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

21 January 2018

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune responses to all ErbB family receptors detectable in serum of cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic immunization against neu/erbB2 transgenic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301396

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3301396

1 reference

Europe PubMed Central

23 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

23 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40811138&oldid=1790647774"